Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1998
09/15/1998CA1340047C 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid, a process for the preparation thereof, the use thereof as pharmaceuticals, and intermediates
09/14/1998CA2231977A1 Aqueous suspension of loteprednol etabonate
09/14/1998CA2225591A1 Platinum (iv) complex and pharmaceutical composition comprising the same
09/13/1998CA2231765A1 Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
09/12/1998CA2229621A1 Solid, at least two-phase formulations of an opioid analgesic with delayed release
09/12/1998CA2229111A1 New secomacrolides from class of erythromycins and process for their preparation
09/11/1998WO1998039486A1 Methods and compositions for the treatment of injury to the central nervous system
09/11/1998WO1998039435A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors
09/11/1998WO1998039434A1 Methods and reagents for modulating apoptosis
09/11/1998WO1998039429A2 Compositions for treatment of disorders involving programmed cell death
09/11/1998WO1998039353A1 Improved chimeric oligonucleotide vectors
09/11/1998WO1998039352A1 Novel bicyclonucleoside and oligonucleotide analogues
09/11/1998WO1998039343A1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase
09/11/1998WO1998039332A1 2-aryl-naphthyridin-4-ones as antitumor agents
09/11/1998WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/11/1998WO1998039328A1 Substituted 2,4-diaminopyrimidines
09/11/1998WO1998039327A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
09/11/1998WO1998039323A1 Anti-mitotic agents which inhibit tubulin polymerization
09/11/1998WO1998039322A1 Method for preparing 2-thienylethylamine derivatives
09/11/1998WO1998039311A1 Antibacterial heterocyclic amino acid derivatives
09/11/1998WO1998039303A1 Small molecules useful in the treatment of inflammatory disease
09/11/1998WO1998039301A1 1-(isoquinolin-1-yl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands
09/11/1998WO1998039299A1 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors
09/11/1998WO1998039296A1 (-)e-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine and its antidiarrhoeal use
09/11/1998WO1998039293A2 13-thia prostaglandins for use in glaucoma therapy
09/11/1998WO1998039292A1 20-epi-22(r)-lower alkyl-substituted vitamin d derivatives and calcium metabolism improving agents containing the same as the active ingredient
09/11/1998WO1998039291A1 Compounds
09/11/1998WO1998039287A1 Benzanthrone compounds and antiviral uses thereof
09/11/1998WO1998039284A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
09/11/1998WO1998039280A1 Phenylpropenone compounds and medicines containing the same
09/11/1998WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
09/11/1998WO1998039030A1 Vaccine composition for preventing or treating c hepatitis
09/11/1998WO1998039024A1 Selective mmp inhibitors having reduced side-effects
09/11/1998WO1998039018A1 Plant extract compositions, method of preparation, and pharmaceutical compositions containing them
09/11/1998WO1998039015A1 Opthalmic composition
09/11/1998WO1998039014A1 Phagocytosis activator compositions and their use
09/11/1998WO1998039013A1 Composition and method for treating cancer and immunological disorders resulting in chronic conditions
09/11/1998WO1998039012A1 USE OF A 7α-METHYL-17α-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS
09/11/1998WO1998039011A1 Photosensitizer conjugates for pathogen targeting
09/11/1998WO1998039009A1 Method of treating a tumor
09/11/1998WO1998039008A1 Methods and compositions for protecting against cardiac ischemia by administering adenosine a2a receptor antagonists
09/11/1998WO1998039007A1 Supression of cyclin kinase 2 activity for prevention and treatment of dna viral infections
09/11/1998WO1998039006A1 Troglitazone compounds for treating climacteric
09/11/1998WO1998039005A1 Pharmaceutical composition for the treatment of so-called restless legs
09/11/1998WO1998039004A1 Anhydrovinblastine for the treatment of cervical and lung cancer
09/11/1998WO1998039003A1 Use of (+)mefloquine for the treatment of malaria
09/11/1998WO1998039002A1 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
09/11/1998WO1998039001A1 Starter kit containing nicotinic acid compositions
09/11/1998WO1998039000A1 Use of cholinesterase inhibitors to treat disorders of attention
09/11/1998WO1998038999A1 The use of levobupivacaine in paediatric surgery
09/11/1998WO1998038998A1 The use of levobupivacaine or ropivacaine in treating migraine
09/11/1998WO1998038997A1 Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
09/11/1998WO1998038996A1 The use of levobupivacaine in facial surgery
09/11/1998WO1998038995A1 Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
09/11/1998WO1998038994A2 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
09/11/1998WO1998038993A1 Method of suppressing tumor growth with combinations of isoprenoids and statins
09/11/1998WO1998038990A1 Method of treating trauma associated with brain, spinal cord or peripheral nerve injury using carbobenzyloxy n-protected di- and tripeptide phenylalaninals
09/11/1998WO1998038989A1 Preparations containing excitatory amino acid antagonists relieved in side effects
09/11/1998WO1998038988A1 Use of pivagabin to prepare pharmaceutical compositions
09/11/1998WO1998038987A1 Pharmaceutical formulations containing poorly soluble drug substances
09/11/1998WO1998038986A2 Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections
09/11/1998WO1998038985A2 Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases
09/11/1998WO1998038984A2 Formulations for hydrophobic pharmaceutical agents
09/11/1998WO1998038983A2 Swallow tablet comprising paracetamol
09/11/1998WO1998038982A1 Composition for the treatment of exercise induced pulmonary hemorrhage and inhaler for administering said composition
09/11/1998WO1998038980A1 Pharmaceutical or cosmetic composition containing at least one retinoid
09/11/1998WO1998038966A1 Sunscreen compositions containing damaged rna fragments
09/11/1998WO1998038862A1 6-halo-or nitrate-substituted paclitaxels
09/11/1998WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
09/11/1998WO1998038854A1 Pharmaceutical composition and methods for using it
09/11/1998WO1998031393A3 Polysaccharide-peptide-conjugates
09/11/1998WO1998031355A3 Pharmaceutical composition comprising n-propylnorapomorphine and cathecol-o-methyl-transferase inhibitor for treating parkinson's disease
09/11/1998WO1998030213A3 Use of the AH receptor and AH receptor ligands to treat or prevent the cytopathicity of viral infection
09/11/1998WO1998029095A3 Sustained release cisapride mini-tablet formulation
09/11/1998WO1998027961A3 Antitussive drugs delivered by partially coated ion exchange resins
09/11/1998WO1998027960A3 A nitroimidazole gel composition
09/11/1998CA2591710A1 Starter kit containing nicotinic acid compositions
09/11/1998CA2574987A1 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
09/11/1998CA2287531A1 Supression of cyclin kinase 2 activity for prevention and treatment of dna viral infections
09/11/1998CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/11/1998CA2283791A1 Troglitazone compounds for treating climacteric
09/11/1998CA2283471A1 Anti-mitotic agents which inhibit tubulin polymerization
09/11/1998CA2283452A1 Composition and method for treating cancer and immunological disorders resulting in chronic conditions
09/11/1998CA2283449A1 Methods and compositions for protecting against cardiac ischemia by administering adenosine a2a receptor antagonists
09/11/1998CA2283418A1 Use of a 7.alpha.-methyl-17.alpha.-ethynyl-estrane derivative for the treatment of atherosclerosis
09/11/1998CA2283415A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
09/11/1998CA2283333A1 Method of suppressing tumor growth with combinations of isoprenoids and statins
09/11/1998CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
09/11/1998CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
09/11/1998CA2283257A1 Phenylpropenone compounds and medicines containing the same
09/11/1998CA2283256A1 1-(isoquinolin-1-yl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands
09/11/1998CA2283151A1 Pharmaceutical or cosmetic composition containing at least one retinoid
09/11/1998CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/11/1998CA2283122A1 Plant extract compositions, method of preparation, and pharmaceutical compositions containing them
09/11/1998CA2283076A1 Vaccine composition for preventing or treating c hepatitis
09/11/1998CA2283068A1 Methods and compositions for the treatment of injury to the central nervous system
09/11/1998CA2282851A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
09/11/1998CA2282691A1 Antibacterial heterocyclic amino acid derivatives
09/11/1998CA2282408A1 6-halo-or nitrate-substituted paclitaxels
09/11/1998CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds
1 ... 6609 6610 6611 6612 6613 6614 6615 6616 6617 6618 6619 6620 6621 6622 6623 6624 6625 6626 6627 6628 6629 ... 7860